Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Norway between 2010 and 2019: A Time-Series Modelling Study
RSV significantly contributes to hospitalisations and deaths in adults in Norway, particularly among older adults and younger adults with underlying diseases. The introduction of RSV vaccines can have a substantial public health impact in reducing the burden of RSV-attributable cardiovascular and respiratory events.
Authors
- Maribel Casas (ORCID: https://orcid.org/0000-0002-2112-6740)
- Pimnara Peerawaranun (ORCID: https://orcid.org/0000-0002-3746-6846)
- Worku Biyadgie Ewnetu (ORCID: https://orcid.org/0000-0002-3650-2016)
- Caihua Liang (ORCID: https://orcid.org/0009-0004-8375-631X)
- Tor Molden
- Bradford D. Gessner (ORCID: https://orcid.org/0000-0002-6216-7194)
- Elizabeth Begier (ORCID: https://orcid.org/0000-0002-1287-5416)
- Robin Bruyndonckx (ORCID: https://orcid.org/0000-0002-4217-2869)
- Aleksandra Polkowska-Kramek
- Somsuvro Basu
- Mikel Esnaola
- Solomon Molalign Moges
Institutions
- Pfizer (United States) (US)
- Pfizer (Ireland) (IE)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Epidemiology and Global Health
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1007/s44197-025-00448-0
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71